Compare Charles River Laboratories Intl. Inc (CRL) vs Ecopetrol SA (EC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Charles River Laboratories Intl. Inc vs Ecopetrol SA — how do they compare? Charles River Laboratories Intl. Inc trades at $232.76 (market cap $11.14B), while Ecopetrol SA trades at $16.17 (market cap $29.46B). The key difference: Ecopetrol SA is far larger — about 2.6× Charles River Laboratories Intl. Inc's market cap, and Ecopetrol SA pays a 4.02% dividend while Charles River Laboratories Intl. Inc pays none. Which is the better fit depends on your goals.
| CRL | EC | |
|---|---|---|
Market Cap | $11.14B | $29.46B |
Sector | Health | Energy |
52-Week High | $233.60 | $16.58 |
52-Week Low | $145.57 | $8.29 |
Enterprise Value | $14.00B | $57.24B |
Dividend Yield | — | 4.02% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Charles River Laboratories (CRL) trades at $229.75, down 1.57% on the day, near its consensus price target of $229.80. The stock shows a bullish technical trend with strong moving average signals and support at $225. Fundamentally, CRL has beaten EPS estimates for three consecutive quarters but reported a net loss of $144.34 million in 2025, with negative profit margins. Recent news highlights collaborations in AI and NGS services, supporting growth prospects.
Outlook remains mixed: analyst consensus is strongly bullish with 72% buy ratings and a high target of $260, but profitability challenges and high P/E of 684.85 pose risks. Cash flow stability and strategic partnerships offer upside, while margin pressures and debt levels require monitoring for sustained recovery.
Ecopetrol (EC) trades at $15.88, up 1.93% with a bullish technical signal from moving averages. The stock shows mixed earnings performance with recent misses but maintains solid profitability with 8.76% net margin and 13.01% ROE. Recent positive developments include a collective bargaining agreement with workers and S&P credit rating affirmation. Valuation appears reasonable with P/E of 11.31 and P/S of 0.99, trading near analyst consensus target of $14.63.
EC presents a balanced opportunity with attractive valuation metrics and stable dividend yield, though facing revenue decline from $159.6B in 2022 to $119.7B in 2025. Key risks include ongoing revenue pressure, debt levels at 42.51% of assets, and oil price volatility. Analyst sentiment is cautious with 27% buy ratings versus 55% hold, suggesting limited near-term upside potential from current levels.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Charles River Laboratories Intl. Inc
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
Read more on CRL →About Ecopetrol SA
Ecopetrol SA is a vertically integrated oil company with operations in Latin America and the United States Gulf Coast. Based out of Colombia, the company explores, develops, and conducts production activities in various countries. Ecopetrol works as the primary operator or partner in a joint venture, in a host of assets held onshore and offshore. Along with production, the company refines and markets crude oils and byproducts produced from its fields. Crude products are moved by Ecopetrol through a series of pipelines throughout Colombia, along with a network of third-party production centers and facilities.
Read more on EC →
